Publicador de continguts

Recerca

Elimination of Viral Hepatitis in Sub-Saharan Africa: Challenges and Opportunities

Data
23/05/2018
Hora
15.00 h
Lloc
Room15 (Manel Corachán), Facultat de Medicina i Ciències de la Salut (Campus Clínic, UB)
(Casanova, 143) Barcelona
Ponent
Gilles Wandeler (University Hospital Bern)

Viral hepatitis infections are major causes of end-stage liver disease and mortality globally. Despite the availability of potent antiviral therapies for HBV and HCV infections, hepatitis-related mortality is increasing. Recently, the World Health Organization called for the development of tailored strategies to reach the elimination of HBV and HCV infections as major public health problems by 2030. Is this objective realistic? What will it take to get there?

Gilles Wandeler, from the University Hospital Bern, will offer an open seminar with the aim to discuss recent achievements and highlight the challenges ahead on the road to elimination of viral hepatitis in sub-Saharan Africa.

Gilles Wandeler

He is an attending physician at the Department of Infectious Diseases, University Hospital Bern, and a senior researcher at the Institute of Social and Preventive Medicine, University of Bern. He obtained a master’s degree in Public Health at the London School of Hygiene and Tropical Medicine and started his research career within the framework of the Swiss HIV Cohort Study. He leads numerous projects on HIV and viral hepatitis infections in sub-Saharan Africa and Switzerland, mainly funded by the NIH and the Swiss National Science Foundation. He’s a member of the scientific Board of the Swiss HIV cohort Study and of the steering committee of EuroSIDA. He teaches at the Universities of Bern, Bordeaux and Barcelona.